Deciphering the Role and Signaling Pathways of PKCα in Luminal A Breast Cancer Cells

• Published in: International journal of molecular sciences Vol. 23; no. 22; p. 14023
• Main Authors: Serrano-López, Emilio M, Coronado-Parra, Teresa, Marín-Vicente, Consuelo, Szallasi, Zoltan, Gómez-Abellán, Victoria, López-Andreo, María José, Gragera, Marcos, Gómez-Fernández, Juan C, López-Nicolás, Rubén, Corbalán-García, Senena
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 14.11.2022; MDPI
• Subjects: 1-Phosphatidylinositol 3-kinase; AKT protein; Apoptosis; Breast cancer; Cancer therapies; Cell differentiation; Cell Proliferation; ErbB-2 protein; Extracellular signal-regulated kinase; Gene expression; Genotype & phenotype; Humans; Interferon; Kinases; Localization; Neoplasms; p53 Protein; Phenotypes; Phosphatidylinositol 3-Kinases - metabolism; Phosphorylation; PKC; Protein expression; Protein kinase C; Protein Kinase C - metabolism; Protein Kinase C-alpha - genetics; Protein Kinase C-alpha - metabolism; Proteins; Signal Transduction; signaling pathways; targeted therapy; Transcription factors; Tumor suppressor genes; Tumors; targeted therapy; PKC; breast cancer; kinases; signaling pathways
• ISSN: 1422-0067; 1661-6596; 1422-0067
• DOI: 10.3390/ijms232214023

Protein kinase C (PKC) comprises a family of highly related serine/threonine protein kinases involved in multiple signaling pathways, which control cell proliferation, survival, and differentiation. The role of PKCα in cancer has been studied for many years. However, it has been impossible to establish whether PKCα acts as an oncogene or a tumor suppressor. Here, we analyzed the importance of PKCα in cellular processes such as proliferation, migration, or apoptosis by inhibiting its gene expression in a luminal A breast cancer cell line (MCF-7). Differential expression analysis and phospho-kinase arrays of PKCα-KD vs. PKCα-WT MCF-7 cells identified an essential set of proteins and oncogenic kinases of the JAK/STAT and PI3K/AKT pathways that were down-regulated, whereas IGF1R, ERK1/2, and p53 were up-regulated. In addition, unexpected genes related to the interferon pathway appeared down-regulated, while PLC, ERBB4, or PDGFA displayed up-regulated. The integration of this information clearly showed us the usefulness of inhibiting a multifunctional kinase-like PKCα in the first step to control the tumor phenotype. Then allowing us to design a possible selection of specific inhibitors for the unexpected up-regulated pathways to further provide a second step of treatment to inhibit the proliferation and migration of MCF-7 cells. The results of this study suggest that PKCα plays an oncogenic role in this type of breast cancer model. In addition, it reveals the signaling mode of PKCα at both gene expression and kinase activation. In this way, a wide range of proteins can implement a new strategy to fine-tune the control of crucial functions in these cells and pave the way for designing targeted cancer therapies.